Five ‘Big Idea’ Biotech Trends To Watch In 2017

Five ‘Big Idea’ Biotech Trends To Watch In 2017

(Photo credit should read REMY GABALDA/AFP/Getty Images)

Different types of stories cross my radar as a biotech journalist every day.

There are partnerships between established drugmakers that need new products and the little aspiring companies that need cash to develop their thing. Stories about clinical trial results that move markets. Regulatory actions that make or break companies and investors.

But for me, there’s something especially fun about talking with scientific entrepreneurs who raised their first big wad of investment cash. They’re latching onto some kernel of insight from a discovery. Or maybe they have a vision for stitching together a set of technologies. Either way, they are venturing into a great unknown to see if they can make a big step ahead in medicine. They often have insights that put them years ahead of the lumbering drug giants.

 

Source: https://www.forbes.com/sites/luketimmerman/2016/12/27/five-big-idea-biotech-trends-to-watch-in-2017/2/#6368d858f501

Related Post

More New Cancer Drugs Mean Higher Costs But Also L...
views 684
More New Cancer Drugs Mean Higher Costs But Also Longer Lives by MAGGIE FOX Spending on cancer treatments has spiked past the $1...
Spotlight – KRS: A cut away from release in ...
views 4142
Spotlight KRS: A cut away from release in exosomes  View ORCID Profile  Catherine Rabouille DOI: 10.1083/jcb.2...
의약바이오컨버젼스연구단 연구원 채용...
views 288
<서울대학교 의약바이오컨버젼스연구단 연구원 채용>미래창조과학부 글로벌프론티어 연구개발사업의 일환으로, 혁신을 통하여 신약개발의 새로운 파라다임을 제시하고자 출범한 서울대학교 의약바이오컨버젼스연구단에서 아래와 같은 업무를 수행할 수 있는 성실하고 책임감있는 연...
이진영 박사과정, AARS 2013 Oral Presentation Award 수상...
views 229
연구단 이진영 박사과정 학생이 10월 6일~11일 일본 하코네에서 열린 AARS 2013에서 Oral Presentation Award를 수상하였습니다.발표 제목은 Methionyl-tRNA Synthetase-mediated Misacylation as a ...

CONTACT US

We're not around right now. But you can send us an email and we'll get back to you, asap.

Sending

©2010-2018 Medicinal Bioconvergence Research Center. All rights reserved.

Log in with your credentials

Forgot your details?

Skip to toolbar